Literature DB >> 6656870

Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids.

H Alexander, D A Johnson, J Rosen, L Jerabek, N Green, I L Weissman, R A Lerner.   

Abstract

Recent studies have shown that short chemically synthesized peptides very often induce antibodies which react with the cognate sequence in the intact folded protein. Since such antibodies react with known regions of proteins, they are of predetermined specificity and offer a precision not previously possible with immunological probes. A basic concept emerging from the use of such antibodies in viral systems is that the differential immunogenicity of closely related proteins can be mimicked by short peptides which span the regions of sequence variation. To generalize this concept, we have studied the two Thy-1 proteins which vary by only a single amino acid. Chemically synthesized peptides differing in only one out of 19 amino acids were able to induce allospecific antisera. Thus, single amino acid changes have similar effects on the immunogenicity of proteins and small peptides, even though the latter are free from constraints provided by neighbouring structures in the tertiary configuration of the intact folded proteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6656870     DOI: 10.1038/306697a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  11 in total

1.  Structural analysis of the carboxy terminus of bacteriophage lambda repressor determined by antipeptide antibodies.

Authors:  R Sussman; H B Alexander
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

2.  Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.

Authors:  H M Geysen; S J Barteling; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.

Authors:  T Tanaka; D J Slamon; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.

Authors:  R Clark; G Wong; N Arnheim; D Nitecki; F McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides.

Authors:  T Mathiesen; F Chiodi; P A Broliden; J Albert; R A Houghten; G Utter; B Wahren; E Norrby
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

6.  Type-specific immunodetection of human heart fatty acid-binding protein with polyclonal anti-peptide antibodies.

Authors:  A H Kleine; J F Glatz; F A van Nieuwenhoven; M I Vallinga; M H Salden; F T Bosman; W J Boersma; N D Zegers; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

7.  Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2.

Authors:  A Altman; J M Cardenas; R A Houghten; F J Dixon; A N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides.

Authors:  M S Smyth; A Trudgett; E M Hoey; S J Martin; F Brown
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface.

Authors:  A T Bentley; P E Klebba
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

10.  Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease.

Authors:  P L Schwimmbeck; D T Yu; M B Oldstone
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.